It has been clinically proven to alleviate a number of conditions, including osteoarthritis, fibromyalgia, neurodegenerative diseases, depression, and liver disease. For patients with major depressive disorder, SAMe has been shown to be effective not only compared to standard antidepressants, but also in non-responders to selective serotonin reuptake inhibitors (SSRIs). It has also been shown to reduce the incidence of sexual dysfunction that commonly accompanies SSRI/SNRI treatment. SAMe has also shown comparable efficacy for osteoarthritis to NSAIDs, including celecoxib. More importantly, this is likely due to increased cartilage formation, glutathione production, DNA methylation, and gene expression that contribute to its effectiveness—a stark contrast to pharmaceutical pain relievers. Research also suggests benefits for neurodegenerative diseases and potentially for improving endothelial function.
Adults: SAMe should always be taken on an empty stomach and for at least 2 weeks, after which the effects should be observed. For mood balance: 1 to 4 tablets 2 times daily or as directed by a healthcare professional. Consult a healthcare professional for use beyond 6 weeks. For osteoarthritis pain: 2 tablets 3 times daily or as directed by a healthcare professional. Do not exceed 6 tablets per day. Consult a healthcare professional for use beyond 12 weeks.
Medicinal ingredients per tablet: S-Adenosyl-L-Methionine (SAMe) 200 mg Non-medicinal ingredients: Microcrystalline cellulose, coating (talc, glycerin, arginine, vegetable magnesium stearate (lubricant), silica, sodium alginate), stearic acid, vegetable magnesium stearate (lubricant), magnesium hydroxide, silica, calcium oxide.